Current participation in another therapeutic clinical trial Current treatment or participation on another therapeutic clinical trial Current treatment on another therapeutic clinical trial Concurrent participation in another therapeutic clinical trial Concurrent enrollment in another therapeutic clinical trial. Concurrent participation in another therapeutic clinical trial. Is participating in another therapeutic clinical trial Enrollment into another therapeutic clinical trial. Concurrent participation in another therapeutic or imaging clinical trial. Concurrent participation in another therapeutic treatment trial Current treatment on another therapeutic clinical trial Concurrent participation in another therapeutic clinical trial. CAPMATINIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial CERITINIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial REGORAFENIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial ENTRECTINIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial Current treatment on another clinical trial Current treatment on another therapeutic clinical trial Concurrent participation in another therapeutic clinical trial Concurrent treatment with any other anti-neoplastic drug or concurrent participation in another therapeutic clinical trial Concurrent treatment with any other anti-neoplastic drug or concurrent participation in another therapeutic clinical trial Current treatment on another clinical trial; participation in non-therapeutic clinical trials is permissible Current treatment on another therapeutic clinical trial Current participation in another therapeutic clinical trial. Major surgical intervention or participation in a therapeutic clinical trial within days from Day of the first dose of MSCA Current treatment on another therapeutic clinical trial Concurrent participation in another therapeutic clinical trial. Treatment on another therapeutic clinical trial within weeks of enrollment in this trial Current treatment on another therapeutic clinical trial Current treatment on another clinical trial concurrent treatment on another therapeutic clinical trial Concurrent participation in another therapeutic clinical trial Concurrent participation in another therapeutic clinical trial; Concurrent participation in another therapeutic clinical trial Received last dose of study drug on another therapeutic clinical trial within days prior to randomization Current treatment on another therapeutic clinical trial Received last dose of study drug on another therapeutic clinical trial within days prior to enrollment Participation in a therapeutic research trial within the past three months Patient is enrolled in any other therapeutic clinical protocol or investigational trial Actively participating in another therapeutic clinical trial Patient is enrolled in any other therapeutic clinical protocol or investigational trial Concurrent participation in another therapeutic treatment trial. Concurrent participation in another therapeutic clinical trial. current treatment in another clinical trial Enrolled on a therapeutic or supportive care clinical trial Participation in a therapeutic clinical trial Participants must not have been asked previously to participate in another therapeutic cancer clinical trial Current enrollment in a therapeutic clinical trial Intention to enroll in a blinded therapeutic clinical trial Current treatment on another therapeutic clinical trial